Department of Health and Human Services January 14, 2005 – Federal Register Recent Federal Regulation Documents
Results 1 - 12 of 12
Privacy Act of 1974; Report of New System
In accordance with the requirements of the Privacy Act of 1974, we are proposing to establish a new system of records, called the ``Cytology Personnel Record System (CYPERS), HHS/CMS/CMSO, 09-70- 0543.'' The primary purpose of CYPERS is to assure CMS of the accuracy and reliability of gynecologic cytology testing by compliance with the CLIA statutory requirements. This will be accomplished by tracking and monitoring the enrollment, participation, and performance of individual cytotechnologists and physicians participating in CMS approved gynecologic cytology proficiency testing programs. Information retrieved from this system of records will be used to support regulatory, reimbursement, and policy functions performed within the agency or by a contractor or consultant; support constituent requests made to a Congressional representative; and support litigation involving the agency. We have provided background information about the proposed system in the SUPPLEMENTARY INFORMATION section, below. Although the Privacy Act requires only that the ``routine use'' portion of the system be published for comment, CMS invites comments on all portions of this notice. See EFFECTIVE DATES section for comment period.
New Animal Drugs For Use in Animal Feeds; Decoquinate
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Alpharma Inc. The supplemental NADAs provide for the use of single-ingredient decoquinate and chlortetracycline Type A medicated articles to make two-way Type B and Type C medicated feeds for cattle at a broader range of concentrations.
2nd NVAC Workshop on Strengthening the Supply of Vaccines in the U.S.
The Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Program Office is sponsoring the ``2nd NVAC Workshop on Strengthening the Supply of Vaccines in the U.S.'' The purpose of this workshop is to bring stakeholders together to: Develop a progress report on the recommendations made in 2002; identify both continuing and new factors that may threaten a stable vaccine supply; and outline specific actions that can have a durable effect in resolving impediments to the consistent and reliable availability of approved vaccines. The meeting is open to the public.
New Animal Drugs for Use in Animal Feeds; Melengestrol
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Ivy Laboratories, Division of Ivy Animal Health, Inc. The ANADA provides for use of a melengestrol acetate liquid Type A medicated article to make Type C medicated feeds for heifers fed in confinement for slaughter and for heifers intended for breeding.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
